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Abstract  
Introduction:  Lymphoid  malignancies  compose  a  wide  spectrum  of  different  morphologic  and  clinical  syndromes  known  to  vary  widely 
throughout the world. The purpose of this study is to determine the prevalence and time trends of lymphoid malignancies. Methods: A 15 (May 
1st 1996-April 30th 2010) years study of all patients who had lymph node biopsy at the Department of Haematology and Pathology, University of 
Benin Teaching Hospital, Benin City, Nigeria. Results: The 391 patients had a male preponderance (M:F; 1.6:1). An increase in the lymphoid 
malignant cases was noted from 95 cases in the first 5-year interval (1996-2000) to 179 cases in the last 5-year interval (2006-2010) giving an 
average increase of 84.0%. Non-Hodgkins lymphoma (61.1%) and chronic lymphocytic leukaemia (18.2%) were the most frequent followed by 
Hodgkin’s lymphoma and myeloma with equal proportions of 9.0% each. A positive correlation with a significant linear trends was obtained 
(r=0.1949, p<0.0001). Geographic areas at risk were found mainly in patients residing in Delta State (67.0%) which is a major oil producing state 
and Edo State (30.4%) where the hospital is located, both in the Niger Delta Region of Nigeria. Conclusion: Future research into environmental 
agents and genetic makeup/HLA typing of patients can be carried out.  
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Introduction 
 
Lymphoid malignancies compose a wide spectrum of different morphologic and clinical syndromes known to vary widely throughout the world. 
Though the incidence of these malignant tumors has increased steadily worldwide the cause of most lymphoid neoplasms remain unknown [1]. 
Previous reports have even indicated that patients with haematologic malignancies (e.g chronic lymphocytic leukaemia, non-Hodgkin's lymphoma) 
may be at increased risk of second neoplasms [2]. Investigation of trends in incidence rates of lymphoid malignancies is essential for the objective 
assessment  of  health  consequences  because  of  increasing  industrialization  and  urban  westernization  including  lifestyle  changes.  The  relative 
frequency of the occurrence of different histologic and immunophenotypic subtypes varies according to race and geography and this may be 
ascribed to genetic and environmental aetiologic factors [3]. The analysis of lymphoid malignancies in a single institution at different periods of 
time can determine the changing status of the disease in this region. Hence, comparison of incidence and patterns by disease subtype may provide 
critical  clues  for  future  aetiologic  investigation.  We  therefore  aim  in  this  study  to  determine  the  prevalence  and  time  trends  of  lymphoid 
malignancies in Benin City, Nigeria.  
  
  
Methods 
 
The case files of all haematologic admission were extracted by multiple information sources from the medical and histological records of University 
of Benin Teaching Hospital (UBTH), Benin City and recognized pathology laboratories in Nigeria from May 1st 1996- April 30th 2010. The detailed 
study design is that UBTH is a major referral centre serving the South-South geopolitical zone of Nigeria. Patients from the catchment region of the 
country have access to the hospital which is a government based hospital and one of the best known Medical Schools in Nigeria. Those with 
diagnosis of lymphoid malignancies were identified. The temporal trend of prevalence rates and their relation with age, gender and histological 
types of lymphoid neoplasms were studied. The pretherapy, clinical, socioeconomic status and demographic features were analysed. The total 
number of lymphoid malignant cases for each year was specifically noted while the total number of patients with lymphoid malignancies in the 
same time interval was calculated.  
  
Tissue samples were studied by histological examination of surgical biopsy from an accessible nodal site by the Histopathology department. 
Diagnosis was established based on clinical information and cytomorphological diagnostic criteria as recommended by the National Cancer Institute 
(NCI)  [4]  including  well  stained  peripheral  blood  film  by  a  Romanowsky  stain,  bone  marrow  aspiration  cytology  and  trephine  biopsy.  For 
prolymphocytic leukaemia (PLL) diagnosis was according to Melo et al [5]. The diagnostic criteria applied for myeloma is in keeping with the 
Myeloma Task Force Criteria [6] while chronic lymphocytic leukaemia (CLL) is according to Rai [7] and Binet staging [8]. The acute lymphoblastic 
leukaemia (ALL) subtype was based on the morphological criteria of the French- American- British (FAB) co-operative group [9]. Diagnosis of non-
Hodgkin's lymphoma was based on the working formulation. Other laboratory studies include complete blood count, Coombs test, immunologic 
studies which determine monoclonality, serum protein electrophoresis, blood cultures, serum electrolyte and urea, ultrasonography.  
  
Data analysis  
  
Data was analyzed using Instat GraphPadTM version 2.05a statistical software. The statistical methods applied include frequency counts and cross 
tabulations using Yates correction whenever necessary and one-way analysis of variance (ANOVA) for significant association. The results are 
presented as mean±SD, median and range. P-value of  
  
  
Results 
 
The total number of Haemato-oncology admissions between 1996 and June 2010 was 1,081 (721 males and 360 females) comprising at five year 
intervals  of  299  (May  1996-2000),  360(2001-2005)  and  422  (2006-June  2010).  Out  of  these,  the  total  number  of  patients  with  lymphoid 
malignancies admitted and those seen at the outpatients clinic was 391 comprising 95 (24.3%), 117(29.9%) and 179 (45.8%) respectively which 
reveals a progressive time increase in lymphoid malignant cases over the 5-year interval periods. The total bed capacity of the hospital is 680 while 
the catchment population of the hospital is a total population of about 12 million.  
  
An increase in the lymphoid malignant cases was noted from 95 cases in the first 5-year interval (1996-2000) to 179 cases in the last 5-year 
interval  (2006-2010)  giving  an  average  increase  of  84.0%.  Overall  an  increase  in  the  number  of  cases  was  observed.  Figure  1 depicts  the 
progressive time trends in prevalence of the four major lymphoid malignancies encountered in this study at three-year intervals. The mean overall 
number of cases for the 3-year interval was 17.5 ± 4.2, 18.9 ± 5.1 and 23.7± 6.4 with a median of 17.5, 19.5 and 24.5 respectively. The 
relationship was such that there was an increasing trend and that most affected subjects were aged 46-59 years or younger in the latter years 
(2006-2010) compared to a decline in the older patients (>60 years) for the period studied.  
  
Prevalence according to age and gender  
  
The 391 patients comprised 238 males (60.9%) and 153 females (39.1%) with a male to female ratio of 1.6:1. The overall median age was 41.0 
years (range; 1-85 years) with a mean age of 40.0± 21 years (SE± 1.1). The relationship between the age and sex distribution of patients with 
lymphoid malignancies for the various 5-year interval is shown in Table 1. The most frequent age group was 46-59 years with 36.6% less than 45 
years and 19.7% within the paediatric age group (1-17years). Detailed overview of the histological diagnosis and the mean age statistical analysis 
of lymphoid malignant subtypes are shown in Table 2. The mean age of non Hodgkin's lymphoma (NHL) patients was 52.5±22.1 years for males 
and 49.5±22.3 years for females while for Hodgkin's lymphoma (HL), the mean ages were 35.4± 20.0 years in males and 35.8±12.5years in 
females. For chronic lymphocytic leukaemia (CLL) the mean age was 59.1±17.3 years and 56.0±7.2 years for males and females respectively. Page number not for citation purposes  3 
Burkitt's lymphoma (BL) which was frequent in the paediatric age group had a mean age of 6.7±3.8 years for males and 8.9±2.9 years for 
females.  
  
Relative frequency of the lymphoid malignancies  
  
Analysis of the lymphoid neoplasms revealed that NHL (61.1%) and CLL (18.2%) were the most frequent followed by HL and myeloma with equal 
proportion of 9.0% each. The other lymphoid malignancies include acute lymphoblastic leukaemia 34 (8.7%), prolymphocytic leukaemia 22 (5.6%) 
while the least frequent lymphoid malignancy was hairy cell leukeamia (HCL) in 12 patients (3.1%). A male preponderance (M:F) of 2.5:1, 1.5:1, , 
1.3:1 and 1.4:1, was found for NHL, HL, ALL and HCL respectively while a slight female preponderance (M:F) of 1:1:2 and 1:1.1 was found for CLL 
and myeloma respectively as shown in Table 2. In both men and women, the more frequent lymphoid malignancies were NHL and CLL while the 
3rd most frequent malignant disorder in males was BL and in females was myeloma.  
  
Demographic characteristics  
  
Table 3 shows the patients socioeconomic and demographic profile at presentation. The majority of the patients were married (68.8%), some 
were single (27.6%) while 2.0% and 1.5% were widowed and divorced respectively. A total of 354 patients (88.0%) were Christians, 20 (5.1%) 
were Muslims and 17(4.3%) atheists. Geographic areas at risk were found mainly in patients residing in Delta State (66.5%) which is one of the 
major oil producing state and Edo State (30.4%) where the hospital is located, both in the Niger Delta Region of Nigeria. The remaining 3.1% 
were other neighboring states which are still located within the oil producing Niger Delta region of Nigeria. This was further confirmed by the 
Urhobo/isoko ethnic groups in Delta state and the Bini in Edo state recording the highest prevalence of lymphoid malignancies. Close observation 
revealed that the more educated patients (59.6%) presented with lymphoid malignancies. On the whole, 66 patients (16.9%) had no formal 
education, 96 patients (24.6%) had primary education and 119 patients (30.4%) had secondary education while 110 patients (28.1%) had a 
tertiary form of education. A marginally higher risk of lymphoid neoplasm was observed for the lower socioeconomic categories (51.9%). Of the 
391 patients, 82 (21.0%) were civil servant, 81 (20.7%) traders, 61 (15.6%) each were farmers and artisans while the largest socioeconomic class 
106 (27.1%) were unemployed.  
  
  
Discussion 
 
Despite proliferation of epidemiological studies during the past two decades, aetiologies of lymphoid malignancies remain poorly understood and 
characterization of descriptive patterns has been limited [10]. The increasing incidence rate of lymphoid malignancies may be partially explained by 
improved diagnostic skills and health facilities.  
  
Non-Hodgkin's  lymphoma  (61.1%)  and  CLL  (18.2%)  were  the  most  common  lymphoid  malignancies  in  this  study.  The  high  prevalence  of 
lymphoma observed correspond to the incidence rates observed in Europe, Africa and throughout the world [11,12]. A similar study carried out in 
equatorial belt of Africa showed that lymphomas were among the top-ten tumors in the geographical region where pathogens and environmental 
factors have been detected suggesting that they may contribute to lymphomagenesis. [13]. Bhurgri et al [14] reported an increasing incidence and 
time trends in a population-based study carried out in Karachi. However, the incidence of lymphomas as reported from the Kuwait cancer control 
center registry was said to have declined [15]. This difference in time trends may have a genetic basis and differing exposure to environmental 
agents. Current evidence suggests that factors and conditions that precipitate either chronic antigenic stimulation or immunosuppression may 
provide a preferential milieu for development of NHL [16].  
  
The increase in total number of lymphoid malignancies from 90 cases to 164 cases in the time interval studied is similar to the pattern of an 
increasing number and incidence for the various lymphoid subtypes in another study [17]. In the largest series of lymphoma cases ever published 
from a single institution in Thailand over a 15 year period, there was an increase in lymphoma cases from 73 cases per year in the first series to 
189 cases per year in the second series (an increase of 158.9%) [17].The increasing trends of malignancies were attributed to a number of 
factors: First, there is a better histologic evaluation in conjunction with immunohistochemical studies which play an important role in diagnosis. 
Secondly, improved standard of health care system which provide easier patient access to the hospital. The increasing prevalence may also be 
attributed to the increasing incidence of HIV in sub-Saharan African and the use of immunosuppressive therapy. The low prevalence of cases seen 
beyond the age of 80 years is probably due to the peculiar demographic distribution of the population after that age.  
  
Although the sex of an individual confers one of the greatest known risk for contracting lymphoma and leukaemias, very little attention is paid to 
these risks [18]. It has been reported that the male excess in lymphoid cancer is most marked in the youngest age group in NHL and HL while ALL 
shows equal sex ratio in childhood peak [18] or slightly higher male ratio as reported by Rodriquez-Abreu et al [19]. The latter finding was 
observed in this study. The predominance of male in the lymphoid cases was seen in this study except for CLL where female dominance and 
elderly occurrence was further reinforced with a median age of 59 years for males and 56 years for females. The female preponderance recorded 
in CLL has been reported in an earlier study in the same institution [20] and Western region of Nigeria [21]. This difference may probably be due 
to racial or genetic factors. Also notable was that the median age of patients at the time of presentation was younger than in Korea and US 
(45years vs 52years vs 65years) respectively [22]. This might be attributed to the lower frequency of follicular lymphoma that tends to occur in 
older patients which was higher in the other study [22]. The male predominance could be attributed to the fact that males are more exposed to 
occupational agent that predispose to development of malignancies than females. There is also the possibility that males may have more unstable 
genetic composition that does not withstand genetic injury as in females. It may also be that males have a weaker DNA repair apparatus than the 
females. These are areas that will require future research.  
  
In  the  developed  world,  classification  of  lymphomas  is  based  on  morphologic  and  immunophenotypic  features.  Unfortunately, 
immunohistochemistry is not routinely done in our centre, therefore constituting a major limitation in the classification of these malignancies. The Page number not for citation purposes  4 
prevalence of follicular lymphoma in our series was low (3.3%) when compared with that encountered in the US [23] and Thailand [17] but was 
similar to that reported by Intragumorchai et al [24] in another study in Thailand (3.8%). Burkitt's lymphoma is a common malignancy in tropical 
Africa and predisposing factors include malaria and infection with the Epstein-Barr virus. Recent studies suggest that the prevalence of  this 
neoplasm is declining in this environment. In Ibadan, another community in the Western region of Nigeria it seems that what appear to be minor 
changes might actually be a real decline in the incidence of BL and that it might be partly ascribed to improved living conditions and greater control 
of malaria. Myeloma made up to 9.0% of the lymphoid malignancies and was the 3rd most frequent malignant disorder in women in this study 
which is similar to the study carried out in France [25]. This value is higher than the value obtained in other studies in Africa [21] but however 
lower than what was obtained in West Indies [26]. Hairy cell leukemia with the least incidence of 3.1% had a male preponderance and is known to 
have a poor prognosis. In a 10 year survey of HCL in the same institution a total of 0.6 cases/year was recorded [27] as compared to 0.8 
cases/year in this 12 year study with less favorable prognosis.  
  
Socioeconomic constraints have been known to adversely affect the management of lymphoid malignancies in Nigeria [28,29]. Though there is a 
selection bias as it does not represent a true community based report, majority of the patients were found to reside in Delta State, a major oil 
producing state where there are petrochemical industries and gas flare sites. Even the other patients were found to reside in other parts of the 
Niger Delta region of the country. The related environmental pollution from its refinery and petrochemical industries along with yet to be confirmed 
toxic waste deposition and radioactive waste products may have contributed to substantial number of lymphoid malignancies from this region. 
However, other aetiologic factors including genetic and environmental influences have been identified in the past as causes of lymphoma especially 
[30,31]. The increase time trend apart from environmental influences and hazards could also be attributed to other factors: poverty, decreased 
immunosurveillance from problems of under nutrition and malnutrition. It is also possible that some of the increase in the number of cases of 
lymphoid malignancies may be due in part to the increase in population in Nigeria.  
  
The  increasing  tendency  for  people  to  work  outside  their  home  community  'one  of  the  most  striking  of  modern  demographic  changes-has 
relevance to a recent aetiological hypothesis about childhood leukaemia: that a community's immune response to an underlying infection can be 
disturbed by increases in new social contacts [32]. Unemployment which accounted for the highest occupational status include students, applicant 
and pensioners. The various agents in the environment to which subsistence farmers and artisan workers are exposed to has been implicated in 
aetiology of lymphoid malignancies [33]. In Italy, researchers have also demonstrated that farmers and industrial workers have a significant risk 
for haematological malignancies [33].  
  
  
Conclusion 
 
In conclusion, our study shows an increasing time trend in lymphoid malignancies in Nigeria with NHL and CLL being the most frequent. The 
lymphoid malignancy is a disease of the young to middle age group occurring mainly in geographic areas of oil producing states. The significant 
increase in the number of cases and male excess in lymphoid malignancies requires further study regarding lymphomagenesis including research 
into environmental agents that may be implicated.  
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Table 1: The relationship between the age and sex distribution of patients with lymphoid malignancies for  the various year interval 
   1996 – 2000  2001 – 2005  2006 – 2010  Total 
 Age (years)     M  F  M  F  M  F   
 1-17  8  16  19  5  18  11  77 
 18-31  12  4  16  5  25  10  72 
 32-45  10  7  11  10  21  12  71 
46-59  16  9  11  17  29  17  99 
60-73  7  6  13  8  14  7  55 
74-80  1  3  1  0  4  4  13 
 >80  1  0  0  1  1  1  4 
 Total  55  45  71  46  112  62  391 
  
 
 
 
Table 2: Detailed histological diagnosis, incidence, sex ratios and statistical analysis of lymphoid malignant subtypes 
Histological diagnosis  n  %  Male  Female  Mean  Std dev  Age range 
Lymphomas               
  NHL  239  61.1  171  68  52.5  22.1  1-83 
  HL  35  9.0  21  14  32.9  17.7  9-66 
Leukaemias               
  CLL  71  18.2  32  39  55.9  13.3  24-84 
  ALL  34  8.7  19  15  21.2  11.7  4-71 
  PLL  22  5.6  11  11  61.8  17.0  26-79 
  HCL  12  3.1  7  5  51.1  7.8  39-60 
Myeloma  35  9.0  18  17  58.0  8.5  42-70 
NHL- Non- Hodgkin’s lymphoma; HL- Hodgkin’s lymphoma; ALL-Acute lymphoblastic  leukaema; CLL- Chronic lymphocytic leukaemia; 
HCL- Hairy cell leukaemia; PLL- Prolymphocytic leukeamia 
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Table 3: The socio-demographic characteristic of 391 patients with lymphoid malignancies during the study period 
Variables   Frequency  (%) 
Sex     
 Male  238  60.9 
 Female  153  39.1 
      
Marital status     
Single  108  27.6 
Married  269  68.8 
Widowed  8  2.0 
Divorced  6  1.5 
      
Geographical Abode     
Edo  119  30.4 
Delta  260  66.5 
Others  12  3.1 
      
Ethnic Group     
Bini  150  38.4 
Urhobo/Isoko  170  43.5 
Others  71  18.2 
      
Educational status     
Illiterate  66  16.9 
Primary  96  24.6 
Secondary  119  30.4 
Tertiary  110  28.1 
      
Occupational Status     
Civil Service  82  21.0 
Trading  81  20.7 
Artisan  61  15.6 
Farming  61  15.6 
Unemployment  106  27.1 
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